Our top pick for
Beginners
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Vaxxinity stock
Learn how to easily invest in Vaxxinity stock.
Vaxxinity Inc is a biotechnology business based in the US. Vaxxinity shares (VAXX) are listed on the NASDAQ and all prices are listed in US Dollars. Vaxxinity employs 89 staff and has a trailing 12-month revenue of around $49,000.
How to buy shares in Vaxxinity
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VAXX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Vaxxinity stock price (NASDAQ: VAXX)
Use our graph to track the performance of VAXX stocks over time.Vaxxinity shares at a glance
Information last updated 2022-10-03.
| Latest market close | $1.90 |
|---|---|
| 52-week range | $1.51 - $22.77 |
| 50-day moving average | $2.17 |
| 200-day moving average | $3.93 |
| Wall St. target price | $15.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.36 |
Buy Vaxxinity shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Vaxxinity stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vaxxinity price performance over time
Historical closes compared with the close of $1.9 from 2022-10-06
| 1 week (2022-09-29) | -6.86% |
|---|---|
| 1 month (2022-09-07) | -11.63% |
| 3 months (2022-07-07) | 0.53% |
| 6 months (2022-04-07) | -55.40% |
| 1 year (2021-10-03) | N/A |
|---|---|
| 2 years (2020-10-03) | N/A |
| 3 years (2019-10-03) | N/A |
| 5 years (2017-10-03) | N/A |
Vaxxinity financials
| Revenue TTM | $49,000 |
|---|---|
| Gross profit TTM | $-1,871,000 |
| Return on assets TTM | -67.12% |
| Return on equity TTM | -146.38% |
| Profit margin | 0% |
| Book value | $0.90 |
| Market capitalisation | $249.5 million |
TTM: trailing 12 months
Vaxxinity share dividends
We're not expecting Vaxxinity to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (3.66% forward annual dividend yield)
- AstraZeneca PLC ADR (AZN.US) (2.64% forward annual dividend yield)
Vaxxinity overview
Vaxxinity, Inc. , a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. .
Vaxxinity in the news
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of UB-313 for Preventive Treatment of Migraine
Vaxxinity Initiates Rolling Submission for UB-612 COVID-19 Vaccine with MHRA (UK)
Frequently asked questions
What percentage of Vaxxinity is owned by insiders or institutions?Currently 55.925% of Vaxxinity shares are held by insiders and 23.141% by institutions. How many people work for Vaxxinity?
Latest data suggests 89 work at Vaxxinity. When does the fiscal year end for Vaxxinity?
Vaxxinity's fiscal year ends in December. Where is Vaxxinity based?
Vaxxinity's address is: 1717 Main Street, Dallas, TX, United States, 75201 What is Vaxxinity's ISIN number?
Vaxxinity's international securities identification number is: US92244V1044
More guides on Finder
-
How to buy OTC stocks
Find out how to buy OTC stocks and compare brokers who offer access to OTC Markets.
-
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
-
Manganese stocks
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
-
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
-
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
-
Invest in FAANG stocks
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
-
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
-
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
-
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Ask an Expert